Health Care

Medicare open enrollment is just around the corner, and this season could be a busy one with many seniors looking for a new plan because of changes coming to Part D and the launch of the new federally-run health insurance exchanges.

Health-care costs are often the big question mark hanging over boomers’ retirement savings. But with a little planning, boomers can work to take some of the guess work out of savings for retirement. 

Thanksgiving is the time of year we gather around the dinner table to feast on turkey, stuffing and apple pie. Amidst the feast we share with family and friends, it is also time to reflect on the blessings in our lives and what we are thankful for.

The Canadian drug maker agreed to buy contact-lens maker Bausch & Lomb for $8.7 billion, giving Valeant a larger footprint in the $30 billion global market for eye-care products.

Pfizer's talks to acquire Allergan Plc in a $150 billion deal that would see the U.S. drug giant redomicile in Ireland accelerated as the U.S. Treasury prepared to clamp down further on such tax inversions.

Health care has been the leading S&P 500 sector for five consecutive years, and during that time, the Nasdaq Biotech Index has increased more than a whopping 520%.

Pfizer revealed better-than-expected quarterly results Tuesday as the largest U.S. drugmaker plans to split its lines of business. 

The health-care and consumer products company said it earned $3.5 billion, or $1.22 per share, topping Wall Street expectations and key drug sales improved. 

Thermo Fisher Scientific said it will buy Life Technologies for $76 a share, or about $13.6 billion.

U.S. stocks made slight gains in early trading as investors assessed earnings news and digested comments from Federal Reserve Chair Janet Yellen.

The stock market drifted lower Wednesday following a drop in durable goods and news of a big merger between Kraft and Heinz.

Asian stock markets drifted Tuesday, taking a negative cue from Wall Street as the economic outlook for next year clouds.

Asian stock markets were mostly higher Monday after largely positive results from the European Central Bank's stress tests of financial institutions.

Global stocks were uneven Tuesday as weak Chinese manufacturing weighed on sentiment and investors looked ahead to a U.S. jobs report later this week that could cement expectations for a Fed interest rate hike.

Shanghai stocks lost ground on Wednesday despite China's better-than-expected economic growth in the second quarter, with investors still wary after a big slide in Chinese markets.

U.S. stocks mostly rose as trading opened Monday with investors looking ahead to a busy week for earnings news and a meeting by the Federal Reserve on interest rates.

U.S. stock indexes are moving higher as the market rebounds from a loss the day before.

U.S. stock indexes are opening slightly higher as the market rebounds from a loss the day before.

India's top court rejected the Swiss drugmaker's plea for patent protection of its cancer drug Glivec, a move likely to boost the prospects of Indian pharmaceutical firms over their foreign rivals.

The latest developments in the sentencing of a former peanut company executive convicted in a deadly salmonella outbreak from 2008 and 2009.